138 related articles for article (PubMed ID: 8865154)
1. Failure to reject an allografted tumor after elimination of macrophages in mice.
Ushio Y; Yamamoto N; Sanchez-Bueno A; Yoshida R
Microbiol Immunol; 1996; 40(7):489-98. PubMed ID: 8865154
[TBL] [Abstract][Full Text] [Related]
2. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
3. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allografted meth A (H-2d) tumor cells in C57BL/6 (H-2b) mice.
Nomi H; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
Microbiol Immunol; 2007; 51(3):297-306. PubMed ID: 17380049
[TBL] [Abstract][Full Text] [Related]
4. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
Yoneda Y; Yoshida R
J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
Ushio-Umeda Y; Yoshida R
Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.
Yoshida R; Takikawa O; Oku T; Habara-Ohkubo A
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1526-30. PubMed ID: 1996352
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
[TBL] [Abstract][Full Text] [Related]
9. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
11. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
[TBL] [Abstract][Full Text] [Related]
12. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
13. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
[TBL] [Abstract][Full Text] [Related]
14. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Ohyama K
Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
[TBL] [Abstract][Full Text] [Related]
15. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
Alleva DG; Askew D; Burger CJ; Elgert KD
J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ Control of an Effector/Target Combination for Skin Allograft Rejection: Macrophage/Skin Components in Normal Mice or T Cell/Endothelial Cells in IFN-γ-Deficient Mice.
Yoshida R; Maeda S; Tashiro-Yamaji J; Yasuda E; Shibayama Y; Hirose Y; Kubota T
J Interferon Cytokine Res; 2020 Apr; 40(4):207-217. PubMed ID: 32069165
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma: a cytokine essential for rejection of CTL-resistant, virus-infected cells.
Yamaguchi S; Tashiro-Yamaji J; Lee K; Takahashi T; Sano K; Endo Y; Nakanishi M; Eguchi A; Okada M; Nomi H; Yamamoto Y; Takenaka H; Kubota T; Yoshida R
J Interferon Cytokine Res; 2005 Jun; 25(6):328-37. PubMed ID: 15957956
[TBL] [Abstract][Full Text] [Related]
18. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
20. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
Alleva DG; Walker TM; Elgert KD
J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
